In the late 1960s, scientists discovered a miracle drug for Parkinson’s disease — a simple, inexpensive dopamine-replacement ...
Psychedelics and Parkinson’s may trigger hallucinations through the same system, revealing how fragile the balance is between externally and internally generated perception.
Pharmacist and PhD researcher Hannah Cleary tells us about her work on long-acting injectables (LAIs) to improve drug ...
News Medical on MSN
Researchers reveal common synaptic pathway behind Parkinson’s and Alzheimer’s diseases
Parkinson's and Alzheimer's diseases are the two most common neurodegenerative disorders, affecting millions of people worldwide.
TipRanks on MSN
Supernus Pharmaceuticals Reports Strong Q3 2025 Growth
Supernus Pharmaceuticals ( ($SUPN) ) has released its Q3 earnings. Here is a breakdown of the information Supernus Pharmaceuticals presented to ...
The Moscow Times on MSNOpinion
Tatyana Rybakova: Russia's Self-Imposed Isolation Reaches a New Frontier: Medicine
There are two contrasting opinions about Russia’s pharmaceutical market. A common sight on Russian-speaking forums across ...
The pharma company's newer immunology drugs, Skyrizi and Rinvoq, have delivered robust sales growth that's proving to be the ...
A group of scientists from the University of Rochester and other institutions are warning that a common chemical used in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results